The NHL patients had higher PD-1+CD3+ and PD-1+CD3+CD4+ percentages compared with the normal volunteers (median = 9.5 vs. 2.0 and 7.0 vs. 0.8, respectively; p < 0.001). The gene discussed is CD4; the disease is non-Hodgkin lymphoma.